Zobrazeno 1 - 8
of 8
pro vyhledávání: '"S. Lucas Goede"'
Autor:
S Lucas Goede, Linda Rabeneck, Marjolein van Ballegooijen, Ann G Zauber, Lawrence F Paszat, Jeffrey S Hoch, Jean H E Yong, Sonja Kroep, Jill Tinmouth, Iris Lansdorp-Vogelaar
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0172864 (2017)
BACKGROUND:The ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is considering switching from biennial guaiac fecal occult blood test (gFOBT) screening between age 50-74 years to the more sensitive, but also less spe
Externí odkaz:
https://doaj.org/article/71e8c5880de84218a8ea982978a449b8
Autor:
Linda J.W. Bosch, Iris Lansdorp-Vogelaar, Veerle Melotte, Manon van Engeland, S. Lucas Goede, Gerrit A. Meijer, Beatriz Carvalho, Harry J. de Koning, Marjolein van Ballegooijen
Publikováno v:
Clinical Gastroenterology and Hepatology, 16(4), 504-512.e11. W.B. Saunders Ltd
Lansdorp-Vogelaar, I, Goede, S L, Bosch, L J W, Melotte, V, Carvalho, B, van Engeland, M, Meijer, G A, de Koning, H J & van Ballegooijen, M 2018, ' Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening ', Clinical Gastroenterology and Hepatology, vol. 16, no. 4, pp. 504-512.e11 . https://doi.org/10.1016/j.cgh.2017.07.011
Clinical gastroenterology and hepatology, 16(4), 504-12. Elsevier Science
Clinical Gastroenterology and Hepatology, 16(4), 504-+. W.B. Saunders
Lansdorp-Vogelaar, I, Goede, S L, Bosch, L J W, Melotte, V, Carvalho, B, van Engeland, M, Meijer, G A, de Koning, H J & van Ballegooijen, M 2018, ' Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening ', Clinical Gastroenterology and Hepatology, vol. 16, no. 4, pp. 504-512.e11 . https://doi.org/10.1016/j.cgh.2017.07.011
Clinical gastroenterology and hepatology, 16(4), 504-12. Elsevier Science
Clinical Gastroenterology and Hepatology, 16(4), 504-+. W.B. Saunders
BACKGROUND & AIMS: Biomarker assays could increase the accuracy of noninvasive detection of colorectal cancer (CRC); fecal immunochemical tests (FITs) are estimated to miss 27%-47% of CRCs and 70%-80% of advanced adenomas per round of screening. We i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fda4e909ee6f4df76e54fbef272bf509
https://doi.org/10.1016/j.cgh.2017.07.011
https://doi.org/10.1016/j.cgh.2017.07.011
Autor:
Iris Lansdorp-Vogelaar, Ahmedin Jemal, Wu Xiau-Cheng, Jiemin Ma, Marjolein van Ballegooijen, Karen Pawlish, S. Lucas Goede
Publikováno v:
Cancer. 121:3676-3683
BACKGROUND Northeastern states of the United States have shown more progress in reducing colorectal cancer (CRC) incidence and mortality rates than Southern states, and this has resulted in considerable disparities. This study quantified how the disp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77c126c009605e6e4e8d9e08f1548e14
https://doi.org/10.1002/cncr.29561
https://doi.org/10.1002/cncr.29561
Autor:
Jeffrey S Hoch, Jean H E Yong, S. Lucas Goede, Marjolein van Ballegooijen, Linda Rabeneck, Jill Tinmouth, Iris Lansdorp-Vogelaar, Lawrence Paszat, Ann G. Zauber, Sonja Kroep
Publikováno v:
PloS one, vol 12, iss 3
PLoS ONE, Vol 12, Iss 3, p e0172864 (2017)
PLoS One (print), 12(3):e0172864. Public Library of Science
PLoS ONE
PLoS ONE, Vol 12, Iss 3, p e0172864 (2017)
PLoS One (print), 12(3):e0172864. Public Library of Science
PLoS ONE
Background The ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is considering switching from biennial guaiac fecal occult blood test (gFOBT) screening between age 50±74 years to the more sensitive, but also less sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cd755f888471080151e4d2ab3591036
https://pure.eur.nl/en/publications/c52d2254-69a9-4445-9f7f-61f536ffc7f8
https://pure.eur.nl/en/publications/c52d2254-69a9-4445-9f7f-61f536ffc7f8
Autor:
Jacqueline C. Reijerink, Monique E. van Leerdam, Iris Lansdorp-Vogelaar, Aafke H. van Roon, Ernst J. Kuipers, Anneke J van Vuuren, Marjolein van Ballegooijen, S. Lucas Goede, J. Dik F. Habbema
Publikováno v:
Gut, 62(5), 727-734. BMJ Publishing Group
Gut
Gut
Objective The sensitivity and specificity of a single faecal immunochemical test (FIT) are limited. The performance of FIT screening can be improved by increasing the screening frequency or by providing more than one sample in each screening round. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3355e4ce03884c020dcb4e3eb25c5cdf
https://doi.org/10.1136/gutjnl-2011-301917
https://doi.org/10.1136/gutjnl-2011-301917
Autor:
Virginia P. Quinn, Douglas A. Corley, Reinier G.S. Meester, Iris Lansdorp-Vogelaar, S. Lucas Goede, Marjolein van Ballegooijen, Theodore R. Levin, Chyke A. Doubeni, Ann G. Zauber
Publikováno v:
Annals of Epidemiology, 25(3), 208-213. Elsevier Inc.
Purpose: Screening is a major contributor to colorectal cancer (CRC) mortality reductions in the United States but is underused. We estimated the fraction of CRC deaths attributable to nonuse of screening to demonstrate the potential benefits from ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41f575a70819d97b9294e7a3b33713b4
https://doi.org/10.1016/j.annepidem.2014.11.011
https://doi.org/10.1016/j.annepidem.2014.11.011
Autor:
S. Lucas Goede, Pieter Spoelstra, Frank ter Borg, Marjolein van Ballegooijen, Else-Mariëtte B. van Heijningen, W. Lesterhuis, Ewout W. Steyerberg, Leopold G.J.B. Engels, Jan J. Koornstra, Evelien Dekker, Clemens J.M. Bolwerk, Iris Lansdorp-Vogelaar, Harry J. de Koning, Robin Timmer, Jan H. Kleibeuker, Juda Vecht, Ernst J. Kuipers
Publikováno v:
EUR Research Portal
Gut, 64(10), 1584-1592. BMJ PUBLISHING GROUP
Gut
Gut, 64(10), 1584-1592. BMJ Publishing Group
Gut, 64(10), 1584-U111. BMJ Publishing Group
Gut, 64(10), 1584-1592. BMJ PUBLISHING GROUP
Gut
Gut, 64(10), 1584-1592. BMJ Publishing Group
Gut, 64(10), 1584-U111. BMJ Publishing Group
Objective To determine adherence to recommended surveillance intervals in clinical practice.Design 2997 successive patients with a first adenoma diagnosis (57% male, mean age 59 years) from 10 hospitals, who underwent colonoscopy between 1998 and 200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d72bcab5e1adcc76f2831c079660abb9
https://pure.eur.nl/en/publications/78d460bc-dc3e-4921-a551-20b485f68501
https://pure.eur.nl/en/publications/78d460bc-dc3e-4921-a551-20b485f68501
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.